Glioma - Wikipedia
.jpg "Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution Iran 2001-2010 - Iranian Journal of Neurosurgery")
Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution Iran 2001-2010 - Iranian Journal of Neurosurgery
Brain Tumour Registry of Canada (BTRC): Survival and Prevalence Report 2010–2017 June 2022
Risk factors for early progression of diffuse low-grade glioma in adults | Chinese Neurosurgical Journal
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients | Radiation Oncology | Full Text
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy | Journal of Cancer Research and Clinical Oncology
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
A) Kaplan-Meier plots of 10-year survival by time period for patients... | Download Scientific Diagram
Kaplan–Meier survival curves for WHO grade II to III diffuse glioma... | Download Scientific Diagram
Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma | Scientific Reports
Advantages of gross total resection in patients with astrocytoma: A population‑based study
Kaplan-Meier overall survival of spinal cord astrocytoma by grade.... | Download Scientific Diagram
Frontiers Publishing Partnerships | Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas
Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis | Anticancer Research
Overall survival of patients with diffuse astrocytomas. The presence of... | Download Scientific Diagram
Biomedicines | Free Full-Text | The Current State of Adult Glial Tumor Patients’ Care in Kazakhstan: Challenges in Diagnosis and Patterns in Survival Outcomes
Astrocytoma Tumors – Symptoms, Diagnosis and Treatments
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas - Modern Pathology
Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors - Frontiers
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
Long-term follow-up in adult patients with low-grade glioma (WHO II) postoperatively irradiated. Analysis of prognostic factors - ScienceDirect
